Form 4: ICU Medical Director Executes RSU Transaction

Director Donald Abbey acquired 1,254 shares of ICU Medical common stock through the vesting of restricted stock units.

Summary

• Director Donald Abbey exercised and vested 1,254 restricted stock units (RSUs) on May 13, 2026.
• Following the transaction, the director holds a total of 6,004 shares of common stock.
• The director was also granted 1,475 new restricted stock units on the same date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director equity compensation.

Positives

• Director maintains a direct ownership stake of 6,004 shares, aligning interests with shareholders.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The director received a new grant of 1,475 restricted stock units which are scheduled to vest on May 13, 2027.

Industry Context

StockSavvy.ai notes that routine RSU vesting and grants for board members are standard corporate governance practices in the medical device sector, reflecting typical long-term incentive compensation structures.

Comparison to Industry Standards

• The transaction follows standard equity compensation practices for directors in the healthcare equipment industry.
• The use of RSUs as a primary vehicle for director compensation is consistent with peers such as Baxter International and Becton Dickinson.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of 1,475 restricted stock units on May 13, 2027.

Key Dates

Keywords

ICU Medical, ICUI, Insider Trading, Form 4, Restricted Stock Units, Director Ownership